916516-89-7

Basic information

• Product Name: 2-(4-bromo-2-chlorophenyl)acetic acid
• Synonyms: 2-(4-bromo-2-chlorophenyl)acetic acid;Benzeneacetic acid, 4-broMo-2-chloro-
• CAS NO: 916516-89-7
• Molecular Formula: C₈H₆BrClO₂
• Molecular Weight: 249
• Mol File: 916516-89-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-(4-bromo-2-chlorophenyl)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-bromo-2-chlorophenyl)acetic acid(916516-89-7)
• EPA Substance Registry System: 2-(4-bromo-2-chlorophenyl)acetic acid(916516-89-7)

Safety Data

• Hazardous Substances Data: 916516-89-7(Hazardous Substances Data)

Usage

General Description

2-(4-bromo-2-chlorophenyl)acetic acid, also known as bromochlorophenylacetic acid, is a chemical compound with the molecular formula C8H6BrClO2. 2-(4-bromo-2-chlorophenyl)acetic acid is a derivative of acetic acid and is commonly used as a raw material in the synthesis of pharmaceutical intermediates. It is also used in the production of agrochemicals and dyes. Bromochlorophenylacetic acid has a variety of applications in organic synthesis and is known for its use as a building block in the creation of other chemical compounds. It is an important reagent in the field of organic chemistry and has potential for further study and development in various industries.

Upstream product

• 67197-54-0 2-(4-bromo-2-chlorophenyl)acetonitrile 
• 59748-90-2 4-Bromo-2-chloro-benzoic Acid 
• 185315-48-4 (4-bromo-2-chlorophenyl)methanol 
• 89720-77-4 4-bromo-1-bromomethyl-2-chlorobenzene 

Downstream Products

• 849934-94-7 methyl 2-(4-bromo-2-chlorophenyl)acetate 
• 1261606-45-4 (4-bromo-2-chlorophenyl)acetic acid ethyl ester 
• 1428758-45-5 C₂₉H₂₉ClN₈O 
• 1330065-78-5 C₃₀H₃₀ClN₇OS 
• 1428760-83-1 3-chloro-4-(8-ethyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)benzonitrile 
• 1428759-01-6 C₂₇H₂₇ClN₁₀O 
• 1428760-84-2 3-chloro-4-(8-ethyl-2-(4-(4-methylpiperazin-1-yl)phenylamino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-N-hydroxybenzimidamide 
• 1428760-85-3 3-chloro-4-[8-ethyl-2-(methylsulfanyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl]benzonitrile 
• 1428760-86-4 3-chloro-4-[8-ethyl-2-(methylsulfanyl)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl]-N'-hydroxy-1-benzenecarboximidamide 
• 1428760-87-5 6-[2-chloro-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-ethyl-2-(methylsulfanyl)pyrido[2,3-d]pyrimidin-7(8H)-one 
• 1428760-88-6 6-[2-chloro-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-8-ethyl-2-(methylsulfinyl)pyrido[2,3-d]pyrimidin-7(8H)-one 
• 1428760-89-7 6-(2-chloro-4-(2-methylthiazol-5-yl)phenyl)-8-ethyl-2-(methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one 
• 1286738-66-6 6-(4-bromo-2-chlorophenyl)-8-ethyl-2-(methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one 
• 849934-95-8 methyl 2-(2-chloro-4-(1,1,2,2-tetramethyl-1λ4,2λ4,4-dioxaborolan-4-yl)phenyl)acetate 

Relevant articles and documents

An optimized synthesis of the potent and selective Pak1 inhibitor FRAX-1036

FRAX-1036 is a p21-activated kinase I inhibitor of significant interest to cancer biologists yet no commercial providers or detailed procedures are available. In this Letter, we chronicle the optimized synthesis of FRAX-1036, one of the most specific Pak1

8-ETHYL-6-(ARYL)PYRIDO [2,3-D]PYRIMIDIN-7(8H) -ONES FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS AND CANCER

Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of CNS disorders such as neuropsychiatric disorders or neurofibromatosis. Also described herein are methods of utilizing PAK inhibitors for the treatment of cancer.